Home » Topics » Disease categories and therapies » Urology

Urology
RSS

IC-486051: a novel PDE4 inhibitor for overactive bladder treatment

May 31, 2005

Preliminary efficacy data does not support further clinical development of palosuran

May 30, 2005

Update on the effects of lanthanum carbonate in dialysis patients

May 30, 2005

Amitriptyline effective but limited by anticholinergic effects in interstitial cystitis

May 27, 2005

Silodosin improves BPH symptoms in phase III trial

May 27, 2005

New data confirm the benefits of TH-070 in symptomatic BPH

May 27, 2005

PT-141 increases sildenafil efficacy in erectile dysfunction

May 26, 2005

Data on dapoxetine for premature ejaculation presented at AUA

May 26, 2005

Phase II study of MN-001 in interstitial cystitis begins

May 26, 2005

Activity of lemuteporfin photodynamic therapy seen in LUTS patients

May 25, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...